(VIANEWS) – Ship Finance International Limited (SFL), Catalyst Pharmaceuticals (CPRX), Chemed Corp (CHE) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Ship Finance International Limited (SFL)
24.3% sales growth and 11.6% return on equity
SFL Corporation Ltd., a maritime and offshore asset owning and chartering company, engages in the ownership, operation, and chartering out of vessels and offshore related assets on medium and long-term charters. The company operates in various sectors of the maritime, and shipping and offshore industries, including oil transportation, dry bulk shipments, chemical transportation, oil products transportation, container transportation, car transportation, and drilling rigs. As of December 31, 2023, the company owned seven crude oil carriers, six oil product tankers, 15 dry bulk carriers, 32 container vessels, one jack-up drilling rig, one ultra-deepwater drilling rig, and five car carriers. It primarily operates in Bermuda, Canada, Cyprus, Liberia, Namibia, Norway, Singapore, the United Kingdom, and the Marshall Islands. The company was formerly known as Ship Finance International Limited and changed its name to SFL Corporation Ltd. in September 2019. SFL Corporation Ltd. was founded in 2003 and is based in Hamilton, Bermuda.
Earnings Per Share
As for profitability, Ship Finance International Limited has a trailing twelve months EPS of $0.97.
PE Ratio
Ship Finance International Limited has a trailing twelve months price to earnings ratio of 14.38. Meaning, the purchaser of the share is investing $14.38 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.6%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 32.5%, now sitting on 799.95M for the twelve trailing months.
Sales Growth
Ship Finance International Limited’s sales growth is 5% for the ongoing quarter and 24.3% for the next.
2. Catalyst Pharmaceuticals (CPRX)
20.4% sales growth and 14.55% return on equity
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was founded in 2002 and is based in Coral Gables, Florida.
Earnings Per Share
As for profitability, Catalyst Pharmaceuticals has a trailing twelve months EPS of $0.63.
PE Ratio
Catalyst Pharmaceuticals has a trailing twelve months price to earnings ratio of 24.16. Meaning, the purchaser of the share is investing $24.16 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.55%.
3. Chemed Corp (CHE)
10% sales growth and 27.87% return on equity
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Earnings Per Share
As for profitability, Chemed Corp has a trailing twelve months EPS of $19.75.
PE Ratio
Chemed Corp has a trailing twelve months price to earnings ratio of 29.15. Meaning, the purchaser of the share is investing $29.15 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.87%.
4. Immersion Corporation (IMMR)
5.8% sales growth and 24.16% return on equity
Immersion Corporation, together with its subsidiaries, creates, designs, develop, and licenses haptic technologies that allow people to use their sense of touch to engage with and experience various digital products in North America, Europe, and Asia. The company provides technology, patent, and combined licenses. It also provides software development kits (SDKs) comprising tools, integration software, and effect libraries that allow for the design, encoding, and playback of tactile effects. In addition, the company offers reference designs and reference technology, engineering and integration services, and software and firmware services. It serves mobile communications, wearables, and consumer electronics; gaming and virtual reality (VR); automotive; and other markets. Immersion Corporation was incorporated in 1993 and is headquartered in Aventura, Florida.
Earnings Per Share
As for profitability, Immersion Corporation has a trailing twelve months EPS of $1.38.
PE Ratio
Immersion Corporation has a trailing twelve months price to earnings ratio of 9.79. Meaning, the purchaser of the share is investing $9.79 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.16%.
Sales Growth
Immersion Corporation’s sales growth is 519.8% for the ongoing quarter and 5.8% for the next.
